Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(11):824; doi:10.1093/jnci/96.11.824
© 2004 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Awards, Appointments, Announcements

{blacksquare} Mitchell Machtay, M.D., director of clinical research in the Department of Radiation Oncology at Thomas Jefferson University Hospital in Philadelphia, has been named vice chair of the department. He has also been appointed the Walter J. Curran Jr., Associate Professor of Radiation Oncology at Jefferson Medical College.

{blacksquare} Gabriel N. Hortobagyi, M.D., was given the Award of Excellence at the 21st Annual Miami Breast Cancer Conference. Hortobagyi is the chairman of the Breast Medical Oncology Department and director of the Breast Cancer Research Program at the University of Texas M. D. Anderson Cancer Center in Houston.

{blacksquare} Three appointments have been made at the University of Iowa Holden Comprehensive Cancer Center in Iowa City:

Larry Oberley, Ph.D., professor of radiation oncology in the Roy J. and Lucille A. Carver College of Medicine, has been named deputy director of the cancer center. Oberley also directs the Free Radical and Radiation Biology Graduate Program.

Gail Bishop, Ph.D., is the new associate director for basic research. Bishop is a distinguished professor of microbiology and internal medicine at the Carver College of Medicine and a researcher with the Iowa City Veterans Affairs Medical Center.

John Lowe, Dr.P.H., has been named associate director for population science. Lowe, professor and head of the department of community and behavioral health at the university’s College of Public Health, also directs the Iowa Tobacco Research Center.

{blacksquare} Three appointments have been made at the H. Lee Moffit Cancer Center and Research Institute, in Tampa, Fla.:

Karen K. Fields, M.D., has been named medical director of the Moffit’s new Total Cancer Care effort, an initiative to provide Florida cancer patients with access to the latest research, treatments, and clinical trials. Fields is also Moffit’s chief of medicine services and medical director for Affiliate and Referring Physicians.

Johnathan M. Lancaster, M.D., has been appointed medical director of the Lifetime Cancer Screening and Prevention Center. Lancaster is a member of the Gynecologic Oncology Program and the Experimental Therapeutics and Risk Assessment, Detection and Intervention Programs. He also leads the Familial Breast and Ovarian Cancer Screening and Prevention Clinic at Lifetime.

Claudio Anasetti, M.D., has been named leader of the Blood and Marrow Transplantation Program. Anasetti comes to Moffit from the Fred Hutchinson Cancer Research Center in Seattle, where he was a professor of medicine and medical director of the Unrelated Donor Marrow Transplant Program.

{blacksquare} Stephen B. Edge, M.D., chair of the Department of Breast and Soft Tissue Surgery at Roswell Park Cancer Institute in Buffalo, N.Y., has been elected to the executive committee of the board of directors of the National Comprehensive Cancer Network, an alliance of 19 leading cancer centers. The committee serves the board in directing strategic, programmatic, and policy initiatives.

{blacksquare} David Spriggs, M.D., has been appointed head of the division of solid tumor oncology at Memorial Sloan-Kettering Cancer Center in New York. Spriggs joined Sloan-Kettering in 1993 as chief of developmental chemotherapy and was named to the Winthrop Rockefeller Chair in Medical Oncology in 2001.

{blacksquare} David M. Goldenberg, M.D., president of the Garden State Cancer Center in Belleville, N.J., has been named Distinguished Scientist of the Year for 2004 by the Clinical Ligand Assay Society. He is being honored for his contributions to the development of radiolabeled antibodies that are used for cancer detection and therapy.

Items in "Awards, Appointments, Announcements" are compiled from notices received by the News section. Not all notices are used; all are edited.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?